drugset / Trial / NCT02194296
Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to investigate the relative bioavailability of a 20 mg ambroxol hydrochloride lozenge compared to 30 mg ambroxol hydrochloride syrup (Mucosolvan®) after dose normalisation
Timeline
- Start
- 1999-06
- Primary completion
- 1999-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ambroxol | Small molecule | 20 mg | — |
| Comparator | Ambroxol | Small molecule | 30 mg | — |
Indications
No indication recorded.